Fasting religiously and still gaining weight. Here's the biological reason.

The FTO gene is your appetite regulator. It sends signals to your brain about whether you’re full or still hungry. When FTO is working normally, fasting windows suppress your appetite naturally because your brain is receiving clear stop-eating signals. Your hunger hormones calm down. You can fast comfortably without constant food thoughts.

The FTO rs9939609 A allele, carried by roughly 45% of people with European ancestry, fundamentally changes this process. People with the A allele experience severely impaired satiety signaling, meaning their brains don’t receive adequate “you’re full” signals even after eating. This isn’t about willpower or discipline; it’s about a biological signal that never arrives.

During intermittent fasting, this becomes a major problem. Your fasting windows feel torturous because your hunger signals never quiet down. You’re not struggling with discipline. Your brain simply isn’t recognizing fullness cues the way it should. Many people with this variant report that fasting makes their hunger obsession worse, not better, because the signal was already broken to begin with.

The ADRB2 gene controls your beta-2 adrenergic receptors, which sit on the surface of your fat cells. During fasting, your body releases adrenaline to trigger these receptors and tell your fat cells to release stored fat for energy. It’s a critical part of fasting’s metabolic benefit. When ADRB2 is working normally, fasting windows activate powerful fat mobilization; your body burns stored fat as fuel.

The Gln27Glu and Arg16Gly variants in ADRB2, found in roughly 40% of the population, reduce how strongly fat cells respond to adrenaline signals. Fat cells with these variants are “deaf” to the signal to release fat, meaning your body struggles to mobilize stored fat even during fasting windows when it should be your primary fuel source.

This is why many people with ADRB2 variants report that fasting doesn’t feel efficient for them. They’re not burning stored fat the way fasting promises. Instead, their bodies cling to fat stores and rely more heavily on muscle breakdown for energy, leaving them feeling depleted and weak during fasts. The fat mobilization that makes fasting metabolically powerful simply isn’t happening.

The PPARG gene controls a protein that regulates how your body decides whether to store or burn fat. It’s particularly important during eating windows when your body is deciding what to do with incoming calories. PPARG also influences how your body responds to low-fat diets. When PPARG is optimized for fat burning, low-fat and fasting-based approaches work well; your body preferentially burns fat rather than storing it.

The Pro12 allele of PPARG, carried by roughly 25% of people, does the opposite. The Pro12 variant promotes extremely efficient fat storage, meaning your body preferentially stores incoming calories as fat rather than using them for energy, and your metabolism resists low-fat diet approaches. This variant was once evolutionarily advantageous when food was scarce; now it works against you when calories are abundant.

For people with this variant, intermittent fasting often backfires because it combines two metabolically unfavorable conditions: fasting windows that trigger preservation of fat stores, and eating windows where your body is primed to store whatever you consume as fat rather than burning it. You’re fasting to reduce calories, but your metabolism is actively resisting fat loss and prioritizing fat storage. The calorie deficit you create during fasting is counteracted by your body’s powerful drive to store fat during eating windows.

The TCF7L2 gene is the strongest common genetic risk factor for type 2 diabetes. It controls how efficiently your pancreas secretes insulin in response to glucose and other hormonal signals. When TCF7L2 is working normally, your insulin response is appropriately timed and proportional to what you eat; your blood sugar stays stable.

The TCF7L2 rs7903146 T allele, carried by roughly 30% of people, disrupts insulin secretion in response to meal timing and glucose loads. People with the T allele have impaired incretin-stimulated insulin secretion, meaning their bodies release insulin too late, too slowly, or in insufficient amounts when they eat, leading to blood sugar spikes and dysregulated glucose control.

Intermittent fasting often worsens this for people with TCF7L2 variants. Extended fasting periods followed by eating windows create large glucose swings. Your body, already struggling to time insulin release properly, faces a massive glucose load after hours of fasting and can’t respond appropriately. Your blood sugar spikes and crashes. You feel energy swings, mood crashes, and intense hunger after eating. Instead of stabilizing your metabolism, fasting destabilizes your glucose control even further.

The MTHFR gene controls methylation, a fundamental metabolic process that affects hundreds of downstream reactions including fat metabolism, energy production, and hormone regulation. MTHFR converts dietary folate into the active form your cells use for methylation reactions. When MTHFR is working well, your metabolism runs efficiently; your cells have the methylated compounds they need to burn fat and produce energy.

The MTHFR C677T variant, carried by roughly 40% of people with European ancestry, reduces the enzyme’s activity by 40-70%. People with C677T have impaired methylation-dependent fat metabolism, meaning their cells struggle to efficiently process dietary fat and their overall metabolic rate is slower than expected. This affects both fasting and eating windows.

During intermittent fasting, this variant creates a double problem. First, your cells already struggle to burn fat efficiently, so fasting windows don’t mobilize stored fat as effectively as they should. Second, the metabolic stress of fasting without adequate methylated compounds makes it harder to maintain lean muscle and stable energy. Many people with MTHFR variants report that fasting makes them feel foggy, depleted, and metabolically stuck. Their weight loss plateaus despite strict adherence to eating windows.

The APOE gene controls apolipoprotein E, a protein that transports cholesterol and fat throughout your body. APOE determines how your metabolism responds to dietary fat intake and how efficiently you clear triglycerides from your bloodstream. APOE comes in three versions: epsilon 2, epsilon 3, and epsilon 4. Each variant has different metabolic implications, particularly around fat handling and cardiovascular response to diet.

APOE4 carriers, present in roughly 25-40% of the population depending on ancestry, have fundamentally different fat metabolism than other types. APOE4 carriers are sensitive to dietary fat intake and tend to have higher triglycerides and LDL cholesterol in response to high-fat diets, while their insulin sensitivity may worsen on very low-carbohydrate approaches.

Intermittent fasting combined with high-fat eating windows (a common approach called “fast and feast”) can be particularly problematic for APOE4 carriers. After a fasting period, they eat a large meal high in fat to meet calorie needs in a short eating window. Their APOE4-influenced metabolism struggles to process the large fat load efficiently, leading to elevated triglycerides, blood sugar dysregulation, and metabolic stress. What’s supposed to be metabolically efficient becomes metabolically destabilizing.